Home > Balance Sheet > INDO US BIOTECH

INDO US BIOTECH
Net Current Assets

    Back to Balance Sheet
INDO US BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Net Current Assets History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹70 Cr₹56 Cr₹48 Cr₹35 Cr₹20 Cr

What is the latest Net Current Assets ratio of INDO US BIOTECH ?

The latest Net Current Assets ratio of INDO US BIOTECH is ₹70 Cr based on Mar2025 Standalone results.
Year Net Current Assets
Mar2025₹70 Cr
Mar2024₹56 Cr
Mar2023₹48 Cr
Mar2022₹35 Cr
Mar2021₹20 Cr

How is Net Current Assets of INDO US BIOTECH Trending?

Years Net Current Assets % Change
Mar2025 ₹70 Cr
26.54
Mar2024 ₹56 Cr
16.82
Mar2023 ₹48 Cr
36.64
Mar2022 ₹35 Cr
72.77
Mar2021 ₹20 Cr -

Compare Net Current Assets of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹202.1 Cr -26.4% -20.1% -48% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,893.1 Cr -0.4% -12.1% -9.1% Stock Analytics
KAVERI SEED COMPANY ₹4,150.9 Cr 12.7% -9.4% -24.4% Stock Analytics
VENKYS (INDIA) ₹1,830.9 Cr 3.2% -18.8% -22.5% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹881.6 Cr 0.2% -8.4% -35.8% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹336.5 Cr 3.3% -17.1% -36.7% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-26.4%

-20.1%

-48%

SENSEX

-2.5%

-6.1%

7%


You may also like the below Video Courses